IRIS
MURINEDDU, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.313
AS - Asia 3.843
SA - Sud America 2.204
EU - Europa 2.045
AF - Africa 149
Continente sconosciuto - Info sul continente non disponibili 135
OC - Oceania 14
AN - Antartide 1
Totale 15.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.158
BR - Brasile 1.919
SG - Singapore 1.387
CN - Cina 1.192
UA - Ucraina 691
VN - Vietnam 361
HK - Hong Kong 315
IT - Italia 306
DE - Germania 291
FR - Francia 183
SE - Svezia 148
TR - Turchia 123
FI - Finlandia 120
AR - Argentina 113
GB - Regno Unito 99
BD - Bangladesh 75
IN - India 72
IQ - Iraq 60
CA - Canada 56
ZA - Sudafrica 45
MX - Messico 43
EC - Ecuador 41
RU - Federazione Russa 39
VE - Venezuela 35
UZ - Uzbekistan 34
CO - Colombia 33
BE - Belgio 31
MA - Marocco 31
JP - Giappone 27
ID - Indonesia 24
KE - Kenya 24
PK - Pakistan 24
KR - Corea 20
PL - Polonia 20
ES - Italia 18
CL - Cile 17
JO - Giordania 17
PY - Paraguay 17
TN - Tunisia 15
AT - Austria 13
AU - Australia 13
CZ - Repubblica Ceca 13
NL - Olanda 12
PE - Perù 12
DO - Repubblica Dominicana 11
RO - Romania 10
UY - Uruguay 10
AL - Albania 9
KZ - Kazakistan 9
OM - Oman 9
CR - Costa Rica 8
DZ - Algeria 8
EU - Europa 8
IR - Iran 8
JM - Giamaica 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
IL - Israele 7
LB - Libano 7
BO - Bolivia 6
EG - Egitto 6
SA - Arabia Saudita 6
BH - Bahrain 5
KG - Kirghizistan 5
MY - Malesia 5
PS - Palestinian Territory 5
RS - Serbia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
HN - Honduras 4
LT - Lituania 4
NG - Nigeria 4
PA - Panama 4
PH - Filippine 4
TH - Thailandia 4
BB - Barbados 3
BY - Bielorussia 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
KH - Cambogia 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BN - Brunei Darussalam 2
BS - Bahamas 2
DK - Danimarca 2
ET - Etiopia 2
IE - Irlanda 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
Totale 15.555
Salva come PNG Salva come JPEG
Città #
Dallas 2.765
Singapore 680
Chandler 675
San Jose 468
Jacksonville 421
Ashburn 322
Hong Kong 306
Beijing 245
Princeton 238
Dearborn 216
Nanjing 192
Council Bluffs 188
Columbus 149
Ho Chi Minh City 134
New York 127
Lauterbourg 119
São Paulo 112
Ann Arbor 109
Wilmington 107
Hanoi 84
Shanghai 84
Izmir 76
Los Angeles 74
Santa Clara 74
Rio de Janeiro 73
Sassari 64
Nanchang 57
Shenyang 56
Belo Horizonte 53
Woodbridge 46
Brasília 44
Hebei 43
Tianjin 42
Changsha 39
Rome 38
Baghdad 31
Jiaxing 31
Tashkent 31
Brussels 30
Guarulhos 27
Johannesburg 27
Tokyo 26
Porto Alegre 24
Curitiba 23
Boardman 22
Buffalo 22
Kunming 22
Nairobi 22
Denver 21
Helsinki 21
Montreal 21
Santo André 20
Andover 19
Buenos Aires 19
Ningbo 19
Orem 19
Seoul 19
Campinas 18
Caxias do Sul 18
Guangzhou 18
Houston 18
Jinan 18
San Francisco 18
Sorocaba 18
Toronto 18
Amman 17
Ribeirão Preto 17
San Mateo 17
Warsaw 17
Da Nang 16
Frankfurt am Main 16
Hangzhou 16
Istanbul 16
Mountain View 16
Munich 16
Norwalk 16
The Dalles 16
Guayaquil 15
Quito 15
Bogotá 14
Haiphong 14
London 14
Brooklyn 13
Contagem 13
Dhaka 13
Fortaleza 13
Goiânia 13
Salvador 13
Zhengzhou 13
Asunción 12
Casablanca 12
Manaus 12
Mumbai 12
Osasco 12
Recife 12
Stockholm 12
São José do Rio Preto 12
Taizhou 12
Chennai 11
Chicago 11
Totale 9.669
Salva come PNG Salva come JPEG
Nome #
Synthesis of Novel Tricyclic N-Acylhydrazones as Tubulin Polymerization Inhibitors 466
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity 289
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 254
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 246
Design and synthesis of novel FGFR inhibitors for the treatment of glioblastoma 241
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and biological evaluation 212
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 190
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 184
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 181
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 169
Composti farmaceutici 168
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 164
Approcci terapeutici contro il cancro. Tradizione e innovazione. 162
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 156
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 155
Antiviral activity of benzotriazole based derivatives 153
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 152
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 150
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 148
Oxadiazoles having antiproliferative activity 147
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 147
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 145
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 144
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 143
A survey of Recent Patents on CB2 Agonists in the Management of Pain 142
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 139
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 139
CAPITOLO 41. Antielmintici 139
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 138
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 136
Pharmaceutical compounds 135
Chimica farmaceutica 135
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 134
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 134
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 134
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 131
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 129
The organic chemistry of drug design and drug action 127
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 126
Chromophore-modified bis-benzo[g]indolecarboxamides: synthesis and citotoxicity of bis-benzo[g]indazole-3-carboxamides and related compounds 125
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 124
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 122
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications 122
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 122
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 122
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 122
Diazacyclic compounds having affinity for opioid receptors 120
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 120
Pharmaceutical Compounds 119
Oxadiazoles having anti proliferative activity 118
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 118
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 118
Pharmaceutical Compounds 116
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 116
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines 115
Pharmaceutical compounds 115
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 115
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 115
Synthesis of biologically active bridged diazabicycloheptanes 114
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 113
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 112
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 111
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 109
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 109
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 109
Pharmaceutical compounds 108
Novel diazabicycloalkane delta opioid agonists 107
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 107
Synthesis and biological evaluation of diazabiciclo[3.3.1]nonanes with a thiother bridge 106
Chimica farmaceutica. Con e-book 106
Sintesi di 1,10-fenantroline chirali a simmetria C2 derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 106
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 106
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 105
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 105
Pharmaceutical compounds 105
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 104
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 104
Pirazoli triciclici: sintesi e valutazione biologica di ligandi per i recettori cannabinoidei con struttura diidroindenopirazolica contenenti differenti sostituenti carbossammidici 104
Pharmaceutical compounds 102
Pharmaceutical compounds 101
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 100
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 99
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 99
Ossadiazoli ad attività antiproliferativa 99
Synthesis and tumor cell lines inhibition of 1,3,4.oxadiazoles linked to tricyclic pyrroles 99
Pharmaceutical compounds 99
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori µ degli oppioidi 99
Pyrazolo-naphthyridines: Design and Synthesis of potential CB-ligands 98
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors 95
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes 95
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives 94
Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties 94
Substituted 3,8-diazabicyclo[3.2.1]octane compounds 93
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 93
Synthesis, pharmacological evaluation and docking studies of pirrole structure-based CB2 receptor antagonists. 93
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists 92
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors 92
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands 91
Sintesi di 1,10-fenantroline chirali a simmetria C2derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 91
Sintesi di nuovi leganti chirali dipiridilmetanici e loro applicazione nella sostituzione allilica palladio-catalizzata 90
Totale 13.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.115
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022505 0 6 9 7 8 5 28 48 51 37 61 245
2022/20231.271 130 78 27 229 110 210 2 161 228 8 56 32
2023/2024396 58 26 15 7 37 81 1 55 3 4 50 59
2024/20253.579 20 20 186 59 124 117 277 583 1.351 573 161 108
2025/20266.509 222 1.544 1.679 875 387 312 669 146 248 245 144 38
2026/2027488 150 338 0 0 0 0 0 0 0 0 0 0
Totale 15.704